Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Guiding principles for pragmatic randomised trials of tuberculosis treatments.
Journal: The Lancet. Infectious diseases
Published: March 30, 2026
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 06, 2023
Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance.
Journal: Frontiers in microbiology
Published: December 22, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing".
Journal: Antimicrobial agents and chemotherapy
Published: September 17, 2021
Safety and Pharmacokinetics of Exebacase in an Infant With Disseminated Staphylococcus aureus Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 27, 2021
Exebacase Is Active In Vitro in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection.
Journal: Antimicrobial agents and chemotherapy
Published: July 06, 2021
Development of a Broth Microdilution Method for Exebacase Susceptibility Testing.
Journal: Antimicrobial agents and chemotherapy
Published: April 27, 2021
Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
Journal: Antimicrobial agents and chemotherapy
Published: March 16, 2021
Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
Journal: The Journal of antimicrobial chemotherapy
Published: February 26, 2021
Arthroscopic "Debridement and Implant Retention" With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection.
Journal: Frontiers in medicine
Published: April 10, 2020
Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2020
Last Updated: 09/26/2026